FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

411529005: Insulin glargine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2466980011 Insulin glargine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2473142015 Insulin glargine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3199401000005111 insulin glargin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Insulin glargine (substance) Is a langtidsvirkende insulin false Inferred relationship Some
Insulin glargine (substance) Is a Human insulin true Inferred relationship Some
Insulin glargine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic hormone (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing insulin glargine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin glargine (substance) Inferred relationship Some 1
Insulin glargine 100iu/mL injection cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glargine (substance) Inferred relationship Some
Insulin glargine 100iu/mL injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glargine (substance) Inferred relationship Some
Insulin glargine 100iu/mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glargine (substance) Inferred relationship Some
Insulin glargine 100u/mL injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glargine (substance) Inferred relationship Some
insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glargine (substance) Inferred relationship Some
insulin glargin (rekombinant human insulinanalog) 100 enheder/ml injektionsvæske, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glargine (substance) Inferred relationship Some
insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin glargine (substance) Inferred relationship Some
Product containing precisely human insulin (as insulin glargine) 1000 unit/10 milliliter conventional release solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Insulin glargine (substance) Inferred relationship Some 1
Product containing precisely human insulin (as insulin glargine) 300 unit/3 milliliter conventional release solution for injection cartridge The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Insulin glargine (substance) Inferred relationship Some 1
Product containing precisely human insulin (as insulin glargine) 300 unit/3 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Insulin glargine (substance) Inferred relationship Some 1
Product containing insulin glargine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin glargine (substance) Inferred relationship Some 1
Product containing only insulin glargine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin glargine (substance) Inferred relationship Some 1
Insulin glargine only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin glargine (substance) Inferred relationship Some 1
Product containing precisely human insulin (as insulin glargine) 100 unit/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Insulin glargine (substance) Inferred relationship Some 1
Insulin glargine 100 unit/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Insulin glargine (substance) Inferred relationship Some 1
Insulin glargine 100 unit/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Insulin glargine (substance) Inferred relationship Some 1
Product containing precisely insulin glargine 300 unit/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Insulin glargine (substance) Inferred relationship Some 1
Product containing precisely insulin glargine 300 unit/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Insulin glargine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start